Articles From: Hagens Berman Investor Alert: 12 Days Remain to File For Lead Plaintiff in Cooper Tire Securities Fraud Lawsuit to Hagens Berman: Statement of Steve W. Berman, lead attorney in US-Based Thalidomide Cases, in Response to Recent $81 million settlement for Australian victims


2014/3/6
SEATTLE , March 6, 2014 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds purchasers of Cooper Rubber & Tire Company ("Cooper" or the "Company") (NYSE: CTB) of the March 18, 2014 deadline to file for lead plaintiff in a securities fraud class-action lawsuit against CTB claiming the Company and its officers caused significant financial losses to stockholders by withholding risks and misrepresenting information associated with a terminated sale to India -based Apollo Tyres Ltd ("Apollo"). Investors or stockholders who suffered significant financial losses related to the case are invited to email CTB@hbsslaw.com for more information.
Sign-up for Hagens Berman Investor Alert: 12 Days Remain to File For Lead Plaintiff in Cooper Tire Securities Fraud Lawsuit investment picks
2014/3/17
Hagens Berman, a consumer law firm that recently settled a case on behalf of Toyota owners for $1.6 billion, has opened an investigation concerning claims by G.M. (NYSE: GM) car owners of potentially serious defects that could cause the cars’ engine and electrical system to shut off while the autos are in operation in 1.6 million G.M. cars – including operation of the airbag systems – a problem that has sparked a government inquiry and has reportedly led to at least 12 deaths and more than 300 crashes.
Sign-up for Hagens Berman Opens Investigation on G.M. Safety Issues investment picks
2014/3/31
Hagens Berman Sobol Shapiro LLP, reminds investors of the May 13, 2014 deadline to file for lead plaintiff in the securities fraud class action against CytRx Corporation (NASDAQ: CYTR) (“CytRx”). Investors who have suffered financial losses can contact Hagens Berman Partner Reed Kathrein, who is leading the firm’s investigation, by emailing CytRx@hbsslaw.com , calling 510-725-3000 or visiting http://hb-securities.com/investigations/CytRx .
Sign-up for Hagens Berman Reminds CytRx Investors of May 13, 2014 Lead Plaintiff Deadline and Continued Securities Fraud Investigation investment picks
2014/4/9
Hagens Berman Sobol Shapiro LLP reminds investors of the May 13, 2014 deadline to file for lead plaintiff in the securities fraud class action against CytRx Corporation (NASDAQ: CYTR) (“CytRx” or “the Company”). Investors who have suffered financial losses can contact Hagens Berman Partner Reed Kathrein, who is leading the firm’s investigation, by emailing CytRx@hbsslaw.com , calling 510-725-3000 or visiting http://hb-securities.com/investigations/CytRx .
Sign-up for Hagens Berman Reminds CytRx Investors of May 13, 2014 Lead Plaintiff Deadline and Inclusion of Those Who Purchased Stock from Feb. 5, 2014 Offering investment picks
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, today reminded investors of the Oct.
Sign-up for Hagens Berman Reminds ECOtality Investors of Oct. 15, 2013, Class-Action Deadline and Continuing Investigation investment picks
2014/3/31
Hagens Berman Sobol Shapiro LLP reminds investors of the May 5, 2014, deadline to file for lead plaintiff in a securities fraud case against Galena Biopharma, Inc. (NASDAQ: GALE) (“Galena” or “the Company”). Investors who bought Galena securities between Nov.
Sign-up for Hagens Berman Reminds Galena Biopharma, Inc. Investors of May 5, 2014, Lead Plaintiff Deadline and Continued Securities Fraud Investigation investment picks
2014/1/21
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds investors of the Jan.
Sign-up for Hagens Berman Reminds Investors 6 Days Remain to File For Lead Plaintiff in Violin Memory Class Action investment picks
2014/2/10
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm representing investors, reminds purchasers of Nu Skin Enterprises, Inc. (NYSE: NUS) (“Nu Skin” or “the Company”) stock that the Class Period has been extended to cover investments between July 10, 2013, and Jan.
Sign-up for Hagens Berman Reminds Investors of Extended Class Period and March 24, 2014 Lead Plaintiff Deadline in Nu Skin Enterprises Class Action investment picks
2014/1/28
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm representing investors, wishes to remind purchasers of Net 1 UEPS Technologies, Inc. (NASDAQ:UEPS) (“UEPS” or “the Company”) stock that the deadline to file for lead plaintiff in a securities class-action lawsuit against the company is Feb.
Sign-up for Hagens Berman Reminds Investors of Feb. 24, 2014, Lead Plaintiff Deadline in Net 1 UEPS Technologies Class Action investment picks
2014/2/10
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm representing investors, reminds purchasers of Cooper Rubber & Tire Company (“Cooper” or the “Company”) (NYSE:CTB) it is investigating CTB’s terminated merger following the filing of a securities class-action lawsuit claiming the Company and its officers caused significant financial losses to stockholders by withholding risks and misrepresenting information associated with a terminated sale to India-based Apollo Tyres Ltd (“Apollo”). Investors or stockholders who suffered significant financial losses related to the case are invited to email CTB@hbsslaw.com for more information.
Sign-up for Hagens Berman Reminds Investors of March 18, 2014 Lead Plaintiff Deadline in Cooper Tire Securities Fraud Investigation investment picks
2014/4/11
Hagens Berman Sobol Shapiro LLP an investor-rights law firm with offices in San Francisco, reminds investors in MagnaChip Semiconductor Corporation (NYSE: MX) (“MagnaChip”) that the lead plaintiff deadline for the securities fraud class action filed in the Northern District of California is May 12, 2014 – not May 5, 2012 as some other firms have advised.
Sign-up for Hagens Berman Reminds Investors of May 12, 2014, Deadline in MagnaChip Semiconductor Corporation Securities Class Action investment picks
2014/4/9
Hagens Berman Sobol Shapiro LLP a national investor-rights law firm, is investigating Geron Corporation (NASDAQ: GERN) (“Geron” or “the Company”) for securities fraud following allegations that the company distributed false and misleading statements to investors concerning its business and prospects, and advises investors of the May 13, 2014 lead plaintiff deadline.
Sign-up for Hagens Berman Reminds Investors of May 13, 2014, Lead Plaintiff Deadline in Geron Securities Class Action investment picks
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds investors of the Oct.
Sign-up for Hagens Berman Reminds Orthofix Investors that 42 Days Remain before Oct. 15, 2013, Lead Plaintiff Deadline investment picks
2013/12/9
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds investors of the Jan.
Sign-up for Hagens Berman Reminds TTS Investors of Jan. 14, 2014 Deadline and Continued Investigation investment picks
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds investors that two weeks remain until the Jan.
Sign-up for Hagens Berman Reminds TTS Investors That Two Weeks Remain Until Deadline to File in Class-Action Lawsuit investment picks
2014/2/10
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm representing investors, wishes to remind purchasers of Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) (“UEPS” or “the Company”) stock that the deadline to file for lead plaintiff in a securities class-action lawsuit against the company is Feb.
Sign-up for Hagens Berman Reminds UEPS Investors of Feb. 24, 2014 Lead Plaintiff Deadline and Continued Investigation investment picks
2013/9/17
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, today reminded investors of the Oct.
Sign-up for Hagens Berman Reminds VELT Investors of Oct. 21, 2013 Deadline and Continued Investigation investment picks
2014/1/2
Following the announcement that Violin Memory Inc. (NYSE:VMEM) (“Violin” or “the Company”) terminated CEO Donald Basile’s employment, Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds investors of the Jan.
Sign-up for Hagens Berman Reminds Violin Memory Investors of Jan. 27th Deadline to File for Lead Plaintiff investment picks
2014/3/10
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds purchasers of Nu Skin Enterprises, Inc. (NYSE:NUS) (“Nu Skin” or “the Company”) stock who purchased between Oct.
Sign-up for Hagens Berman: 14 Days Remain to File for Lead Plaintiff in Nu Skin Class-Action Lawsuit as Stock Continues to Slump from Chinese Investigation investment picks
2014/3/25
National consumer-rights law firm Hagens Berman Sobol Shapiro LLP today announced that purchasers of e-books represented by the firm will soon begin receiving account credits or checks totaling as much as $62 million of a $166 million partial settlement in price-fixing litigation brought by Hagens Berman against Apple (NASDAQ:AAPL) and five e-book publishers.
Sign-up for Hagens Berman: 23 States and Territories Represented by Firm to Receive $62 Million of $166 Million E-Book Partial Settlement over Price-Fixing Allegations investment picks
2014/3/25
National consumer-rights law firm Hagens Berman Sobol Shapiro LLP today announced that California purchasers of e-books will soon begin receiving account credits or checks totaling as much as $17.9 million as a partial settlement in price-fixing litigation brought by Hagens Berman against Apple (NASDAQ:AAPL) and five e-book publishers.
Sign-up for Hagens Berman: California E-Book Purchasers to Receive Share of $166 Settlement over Price-Fixing Allegations investment picks
2014/3/19
Hagens Berman, a consumer-rights law firm that recently settled the $1.6 billion case against Toyota, today announced it has filed a class-action lawsuit seeking statutory penalties and punitive damages against automaker General Motors (NYSE:GM) on behalf of owners of 1.4 million vehicles affected by a safety defect.
Sign-up for Hagens Berman: Consumers Sue G.M. over Ignition Recall – Demand Statutory Penalty of $350 Million, Other Damages investment picks
2014/3/25
National consumer-rights law firm Hagens Berman Sobol Shapiro LLP today announced that Florida purchasers of e-books will soon begin receiving account credits or checks totaling as much as $9.5 million as a partial settlement in price-fixing litigation brought by Hagens Berman against Apple (NASDAQ:AAPL) and five e-book publishers.
Sign-up for Hagens Berman: Florida E-Book Purchasers to Receive Share of $166 Settlement over Price-Fixing Allegations investment picks
2014/3/28
National consumer-rights law firm Hagens Berman Sobol Shapiro LLP announced today that a federal judge handed down two rulings that add to Apple’s (NASDAQ:AAPL) legal woes in its attempt to defend itself of charges the company conspired to illegally inflate the price of e-books.
Sign-up for Hagens Berman: Judge Grants Class Certification in Apple E-Books Antitrust Case and Excludes Apple’s Expert Opinions investment picks
2014/4/3
National consumer-rights law firm Hagens Berman Sobol Shapiro LLP today announced that a recent court’s order denying arbitration from mobile device manufacturer defendants Carrier IQ Inc. (CIQ), Motorola Mobility LLC (NYSE: MMI), Samsung (NYSE: SSNLF) and others, will allow class members to continue the alleged wiretapping case.
Sign-up for Hagens Berman: Judge Strikes Down Arbitration in Alleging Wiretapping Case investment picks
2014/3/19
Consumers today filed a proposed class-action lawsuit against Allergan Inc. (NYSE:AGN) and its pharmaceutical company subsidiary, SkinMedica, claiming that the companies have misbranded and unlawfully marketed Tissue Nutrient Solution (TNS), a skin-care product line containing human growth factors obtained from human foreskin tissue which could increase the risk of cancer and pose other health risks, according to the complaint filed by Hagens Berman Sobol Shapiro LLC.
Sign-up for Hagens Berman: Pharmaceutical Company SkinMedica Selling Misbranded Drug Products as Cosmeceuticals investment picks
Hagens Berman attorneys representing plaintiffs in the US seeking compensation from the manufacturer and distributors of the birth defect-causing drug Thalidomide today lauded a $81 million settlement announced for Australian victims, but said progress for a similar settlement against GlaxoSmithKline (NYSE:GSK) and Sanofi-Aventis (NYSE:SNY) does not appear likely without moving to trial.
Sign-up for Hagens Berman: Statement of Steve W. Berman, lead attorney in US-Based Thalidomide Cases, in Response to Recent $81 million settlement for Australian victims investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Hagens Berman Investor Alert: 12 Days Remain to File For Lead Plaintiff in Cooper Tire Securities Fraud Lawsuit to Hagens Berman: Statement of Steve W. Berman, lead attorney in US-Based Thalidomide Cases, in Response to Recent $81 million settlement for Australian victims
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity